It forces your body to oxidize (burn) stored fat, leading to weight loss
doi: 10.1016/j.eprac.2021.04.001 Summary Keywords semaglutide, overweight, obese, meta-analysis, subgroup Citation Zhang R, Hou Q, Li B, Deng L, Yang Y, Li T, Yao X, Yang L, Lin X, Liao Y, Wang L, Liu Y, Tan J, Wan Z and Shuai P (2023) Efficacy and safety of subcutaneous semaglutide in adults with overweight or obese: a subgroup meta-analysis of randomized controlled trials
Semaglutide is a GLP-1 receptor agonist, which means it mimics the action of the GLP-1 hormone
The most common issues are nausea, vomiting, diarrhea, and constipation
Because Ozempic causes delayed stomach emptying, patients may undergo sedation with partially digested food in their stomachs, even if they stopped eating when their physician asked them to